Asked by: Sarah Bool (Conservative - South Northamptonshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the annual cost of treating (a) patients over 18 and (b) children with Diabetic Ketoacidosis is.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
A central mission of the Government is to build a health and care system that is fit for the future. Tackling preventable ill health, such as type 2 diabetes, is crucial. Shifting the focus from treatment to prevention is one of three shifts for the Government’s mission for a National Health Service that is fit for the future, and is a cornerstone of supporting people to live healthier lives.
Preventing diabetes, like obesity, is a complex issue and requires multi-faceted action across both the public and private sector. Prevention involves collaboration across the public and private sectors to tackle underlying issues such obesity, poor diets, and lifestyle issues.
The Department is taking steps to prevent type 2 diabetes through programmes such as the NHS Health Check, England’s flagship cardiovascular disease prevention programme for those aged between 40 and 74 years old, which aims to identify people at risk of developing type 2 diabetes, as well as heart disease, stroke, kidney disease, and some cases of dementia, and to signpost them to behavioural support such as weight management and clinical treatment if needed.
Once identified, those at risk of developing type 2 diabetes can also be referred by their general practitioner into the Healthier You NHS Diabetes Prevention Programme. The programme is highly effective, cutting the risk of developing type 2 diabetes by 37% for people completing the programme, compared to those who do not attend.
The annual costs of treating patients over 18 years old and children with diabetic ketoacidosis is not available, as this data is not routinely collected and/or analysed nationally.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to improve early and accurate dementia diagnosis as part of the 10 Year Health Plan.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Our health system has struggled to support those with complex needs, including those with dementia. Under the 10-Year Health Plan, those living with dementia will benefit from improved care planning and better services.
We recognise the importance of a timely diagnosis and remain committed to increasing diagnosis rates. The Government’s Dame Barbara Windsor Dementia Goals programme has already invested £13 million into a range of biomarker innovation projects, which include a broad range of biomarker technologies, ranging from an artificial intelligence tool designed to improve the accuracy of blood tests for dementia, to using retinal scans to detect early-onset dementia decades before symptoms. Some of these innovations could support improved diagnosis in the future, if validated for clinical use.
We will deliver the first ever Modern Service framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, expected in 2026.
Asked by: Rachel Gilmour (Liberal Democrat - Tiverton and Minehead)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, what assessment her Department has made of the potential impact of VAT on the affordability of support services for people with (a) permanent disabilities and (b) dementia.
Answered by James Murray - Exchequer Secretary (HM Treasury)
Supplies of welfare services, including the provision of care for people with permanent disabilities and dementia, are exempt from VAT if they are supplied by eligible bodies, such as public bodies or charities.
When developing policy, including on VAT on welfare services, the Treasury carefully considers the impact of its decisions on those sharing any of the nine protected characteristics, including disability, age, sex and race, in line with its statutory obligations under the Public Sector Equality Duty set out in the Equality Act 2010.
More generally, VAT is a broad-based tax on consumption, and the 20 per cent standard rate applies to most goods and services. VAT is the UK’s second largest tax, forecast to raise £180 billion in 2025/26. Exceptions to the standard rate have always been limited and balanced against affordability considerations.
Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to encourage earlier and more accurate diagnosis of dementia.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Our health system has struggled to support those with complex needs, including those with dementia. Under the 10-Year Plan, those living with dementia will benefit from improved care planning and better services.
We will deliver the first ever Modern Service framework for Frailty and Dementia to deliver rapid and significant improvements in the quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, expected in 2026.
Commissioned by the Healthcare Quality Improvement Partnership and funded by NHS England and the Welsh administration, the National Audit of Dementia Memory Service Spotlight reports include data on aspects of the diagnostic process, including waiting times and variation in service delivery in terms of diagnosis speed, neuroimaging use, and post-diagnostic support. The aim is to aid commissioners and providers in planning and targeting improvement where appropriate.
The Government is empowering local leaders with the autonomy they need to provide the best services to their local community, including for those with dementia. That is why we have published the D100: Assessment Tool Pathway programme, which brings together multiple resources into a single, consolidated tool. This will help simplify best practice for system leaders and help create communities and services where the best possible care and support is available to those with dementia. The D100: Pathway Assessment Tool launched in April, with further information available at the Royal College of Psychiatrists’ website, in an online only format.
Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to enable (1) people with dementia to live independently, and (2) their families to care for them at home, for longer.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Our health system has struggled to support those with complex needs, including those with dementia. Under the 10-Year Health Plan, those living with dementia will benefit from improved care planning and better services.
Through the 10-Year Health Plan, we are equipping and supporting carers by making them more visible, empowering their voices in care planning, joining up services, and streamlining their caring tasks by introducing a new ‘MyCarer’ section to the NHS App.
We will deliver the first ever Modern Service framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, expected in 2026. The commission will start a national conversation about what care and support working age adults, older people, and their families expect from adult social care, including exploring the needs of unpaid carers who provide vital care and support.
In England, we continue to fund the locally administered Disabled Facilities Grant (DFG) which helps eligible older and disabled people on low incomes to adapt their homes, through practical changes like installing stair lifts or level access showers, to make them safe and suitable for their needs. We have provided an additional £172 million across this and the last financial year to uplift the DFG, which could provide approximately 15,600 home adaptations to give older and disabled people more independence in their homes. This brings the total funding for the DFG to £711 million in 2024/25 and 2025/26.
Asked by: Rachel Gilmour (Liberal Democrat - Tiverton and Minehead)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the contribution of Community Interest Companies to the provision of day care services for people with early-stage dementia.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Government is committed to ensuring that families have the support that they need. The provision of dementia health care services is the responsibility of local integrated care boards and may include day care services.
Local authorities are best placed to understand and plan for the needs of their population, which is why, under the Care Act 2014, local authorities are tasked with the duty to shape their care market to meet the diverse needs of all people.
Our health system has struggled to support those with complex needs, including those with dementia. Under the 10-Year Plan, those living with dementia will benefit from improved care planning and better services. We will deliver the first ever Modern Service Framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity.
Asked by: Gregory Campbell (Democratic Unionist Party - East Londonderry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people with dementia in (a) 2025 and (b) 2029.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
No specific estimate has been made for the number of people with dementia in 2029.
The Dementia Surveillance Factsheet estimates that, in May 2025, there were 740,640 people aged 65 years old and over estimated to have dementia in England. Of these, 485,653 have been formally diagnosed.
This factsheet uses Primary Care Dementia Data, which replaced the Recorded Dementia Diagnosis data in October 2022.
Asked by: Jo Platt (Labour (Co-op) - Leigh and Atherton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps to introduce a National Services Framework for dementia.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Our health system has struggled to support those with complex needs, including those with dementia. Under the 10 Year Plan, those living with dementia will benefit from improved care planning and better services.
We will deliver the first ever Modern Service Framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, expected in 2026.
The Modern Service Framework for Frailty and Dementia will seek to reduce unwarranted variation and narrow inequality for those living with dementia, and will set national standards for dementia care and redirect National Health Service priorities to provide the best possible care and support.
Asked by: Lord Foulkes of Cumnock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to improve access to clinical trials for new disease-modifying dementia treatments; and how they will ensure that early and accurate diagnosis is prioritised.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Government responsibility for delivering dementia research is shared between the Department of Health and Social Care, with research delivered via the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation.
The Department of Health and Social Care is committed to ensuring that all patients, including those with dementia, have access to cutting-edge clinical trials and innovative, lifesaving treatments.
As an example, the Department, via the NIHR, is investing nearly £50 million into the Dementia Trials Network, a coordinated network of trial sites across the United Kingdom, which will offer people with dementia the opportunity to take part in early phase clinical trials irrespective of where they live. This is complemented by the £20 million Dementia Trials Accelerator, designed to position the UK as the destination of choice for late phase clinical trials in dementia and neurodegenerative diseases.
In partnership with Alzheimer’s Society, Alzheimer’s Research UK, and Alzheimer Scotland, the NIHR also delivers Join Dementia Research, an online platform which enables the involvement of people with and without a dementia diagnosis, as well as carers, to take part in a range of important research, including studies evaluating potential treatments for dementia.
The Government’s Dame Barbara Windsor Dementia Goals programme, which is expected to have nearly £150 million of Government funding allocated to it, or aligned with it, aims to speed up the development of new treatments for dementia and neurodegenerative conditions by accelerating innovations in biomarkers, clinical trials, and implementation.
Our health system has struggled to support those with complex needs, including those with dementia. Under the 10-Year Plan, those living with dementia will benefit from improved care planning and better services. We will deliver the first ever Modern Service Framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, expected in 2026.
We recognise the importance of a timely diagnosis, and remain committed to increasing diagnosis rates and ensuring that people can access any licensed and National Institute for Health and Care Excellence-recommended treatment and/or support they need.
Asked by: Lord Kamall (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what measures are being implemented to enable more people with early-stage dementia to participate in clinical trials for new treatments, and to ensure equitable access to trials across all regions.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Government responsibility for delivering dementia research is shared between the Department of Health and Social Care, with research delivered via the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation.
The Department of Health and Social Care is committed to ensuring that all patients, including those with dementia, have access to cutting-edge clinical trials and innovative, lifesaving treatments.
As an example, the Department, via the NIHR, is investing nearly £50 million into the Dementia Trials Network, a coordinated network of trial sites across the United Kingdom, which will offer people with dementia the opportunity to take part in early phase clinical trials irrespective of where they live. This is complemented by the £20 million Dementia Trials Accelerator, designed to position the UK as the destination of choice for late phase clinical trials in dementia and neurodegenerative diseases.
The NIHR also funds research infrastructure which supports patients and the public to participate in high-quality research, including research on dementia. For example, the aim of the University College London Hospitals’ Biomedical Research Centre’s dementia theme is to develop novel treatments through precision medicine. The theme’s focus on young onset and familial dementias provides key insights into the factors that can cause or speed up neurodegeneration, allowing a window for treatments to be administered, before functional decline occurs.
In partnership with Alzheimer’s Society, Alzheimer’s Research UK, and Alzheimer Scotland, the NIHR also delivers Join Dementia Research, an online platform which enables the involvement of people with and without a dementia diagnosis, as well as carers, to take part in a range of important research, including studies evaluating potential treatments for dementia.
The Government’s Dame Barbara Windsor Dementia Goals programme, which is expected to have nearly £150 million of Government funding allocated to it, or aligned with it, aims to speed up the development of new treatments for dementia and neurodegenerative conditions by accelerating innovations in biomarkers, clinical trials, and implementation.